Loading chat...

NJ A4082

Bill

Status

Introduced

2/19/2026

Primary Sponsor

Annette Quijano

Click for details

Origin

General Assembly

2026-2027 Regular Session

AI Summary

  • Establishes a registration and regulatory framework for hemp-derived cannabinoid products (including Delta-8-THC and other psychoactive cannabinoids) sold in New Jersey, administered by the Cannabis Regulatory Commission.

  • Requires manufacturers and retailers of hemp-derived cannabinoid products to register with a state database and pay registration fees to fund program operations.

  • Prohibits sale of hemp-derived cannabinoid products with detectable THC to persons under 21 years of age, requiring government-issued photo identification verification before purchase.

  • Mandates comprehensive labeling requirements including THC content percentages, serving sizes, ingredient lists, allergen warnings, production dates, and health warnings about intoxication effects and risks during pregnancy.

  • Requires child-resistant, opaque packaging and prohibits marketing that appeals to minors, promotes overconsumption, or uses cartoon characters or toys in branding.

Legislative Description

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

Oversight, Reform and Federal Relations

Last Action

Introduced, Referred to Assembly Oversight, Reform and Federal Relations Committee

2/19/2026

Committee Referrals

Oversight, Reform and Federal Relations2/19/2026

Full Bill Text

No bill text available